Position in DXCM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,437,232
+$1,606,549 QoQ
Shares Held
54,733
+98.4% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0.7308205287486526.ToString("F0")%
Shared 0.ToString("F0")%
None 99.26917947125135.ToString("F0")%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Waverly Advisors, LLC holds $68,136,624 across 14 Medical Devices names. DXCM ranks #7 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
45,828 | $15,058,622 | |
| 2 | ABT |
Abbott Laboratories
|
128,054 | $13,147,304 | |
| 3 | BSX |
Boston Scientific Corp
|
162,989 | $10,227,559 | |
| 4 | MDT |
Medtronic plc
|
106,239 | $9,205,609 | |
| 5 | STE |
STERIS plc
|
34,788 | $7,692,670 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
49,061 | $3,492,161 | |
| 7 | DXCM |
Dexcom Inc
This page
|
54,733 | $3,437,232 | |
| 8 | EW |
Edwards Lifesciences Corp
|
33,583 | $2,689,326 |
All Filings in DXCM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,437,232 | 54,733 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,830,683 | 27,583 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,219,019 | 47,838 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $266,147 | 3,049 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $210,538 | 3,083 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $258,196 | 3,320 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||